Market Overview

Sterne Agee Reiterates Buy on PacWest Bancorp Following CSE Merger Announcement

Share:
Related PACW
Biotechs Among Stocks That Insiders Have Been Buying Lately
Benzinga's Top Initiations

In a report published Friday, Sterne Agee analyst Todd L. Hagerman reiterated a Buy rating and $45.00 price target on PacWest Bancorp (NASDAQ: PACW).

In the report, Sterne Agee noted, “Reiterating our BUY rating as the announced PACW/CSE merger continues apace. Given PACW's strong track record in executing/integrating acquisitions, in addition to the highly complementary pieces of the recently announced deal, our sense is this transformational acquisition may exceed conservative expectations.”

PacWest Bancorp closed on Thursday at $33.92.

Latest Ratings for PACW

DateFirmActionFromTo
Jan 2016BMO CapitalDowngradesOutperformMarket Perform
Dec 2015Wells FargoInitiates Coverage onOutperform
Oct 2015Piper JaffrayInitiates Coverage onOverweight

View More Analyst Ratings for PACW
View the Latest Analyst Ratings

Posted-In: Sterne Agee Todd L. HagermanAnalyst Color Reiteration Analyst Ratings

 

Related Articles (PACW)

View Comments and Join the Discussion!

Get Benzinga's Newsletters